Our Services
Others
- DFPP
- Shockwave
- IV Drip
Mesenchymal stem cells (MSCs) for skin aging are one of the most heavily marketed uses of stem cells, and one of the least proven. Laboratory and animal studies show that MSCs, and the growth factors they release, can increase collagen, reduce collagen-breaking enzymes and thicken aged skin. Human evidence is much thinner. It comes mostly from small studies of cell-free products applied to the skin, not from injecting living cells.
This review explains what goes wrong inside aging skin, how umbilical cord mesenchymal stem cells (UC-MSCs) may help, and what the evidence shows at each level: lab, animal and human. It also covers the real safety questions, how cell quality should be tested, and the legal position in Thailand.
Skin has three main layers. The epidermis on top forms the protective barrier. The dermis below holds collagen and elastin, the proteins that give skin strength and bounce. The fat layer underneath cushions it. The dermis is built and maintained mainly by cells called fibroblasts, which make collagen and elastin (Jo et al., 2021).
With age, the dermis loses fibroblasts, collagen and small blood vessels, and the epidermis gets thinner (Liu et al., 2017). The result is skin that is thinner, drier, less elastic and slower to repair.
Skin ages in two overlapping ways:
| Intrinsic aging | Extrinsic aging | |
| Cause | Time and genetics | Environment: mainly UV light, also smoking and pollution |
| Where it shows | Everywhere, including sun-protected skin | Mostly on the face, neck, hands and forearms |
| Typical changes | Thin, dry, fine lines, slower healing | Thicker, leathery texture, deep lines, uneven pigment, broken vessels |
| Can it be slowed? | Only partly | Largely, with sun protection and not smoking |
Extrinsic aging is the bigger factor for most people. One review estimates that UV radiation accounts for about 80% of visible facial aging (Li et al., 2024). That is why daily sunscreen remains the best-proven anti-aging measure.
Yes. As skin ages, it generally becomes thinner and more easily damaged (Role of Mesenchymal Stem Cells in Skin Aging and Damage, 2025). Both the epidermis and the dermis thin out. There are fewer fibroblasts, less collagen and fewer small blood vessels feeding the skin. Thinner skin bruises and tears more easily and heals more slowly, which is a medical issue as well as a cosmetic one.
Collagen in the dermis is constantly being made and broken down. In young skin the two stay roughly in balance. In aged skin, three changes tip the balance toward loss.
Senescent cells are cells that have stopped dividing but have not died. With age and UV damage, more fibroblasts become senescent. They make less collagen. They also release inflammatory signals and enzymes that damage the surrounding tissue and can push nearby healthy cells toward senescence too. Researchers think this build-up of “worn-out” fibroblasts is one of the main drivers of aging in the dermis.
Matrix metalloproteinases are enzymes that break down collagen and other parts of the skin’s support structure. Normally they help remodel tissue. UV light and inflammation, however, sharply increase their activity, especially MMP-1, which cuts the main collagen fibres. Over years, repeated bursts of MMP activity leave the dermis fragmented and disorganised.
TGF-beta is a key signal that tells fibroblasts to make collagen. It works through a relay of proteins called Smads, which carry the message into the cell’s nucleus and switch on collagen genes. In aged and sun-damaged skin, this pathway is weakened. Fibroblasts respond less to TGF-beta, so they make less new collagen even as MMPs break the old collagen down.
aged skin makes less collagen (weaker TGF-beta/Smad signalling and senescent fibroblasts) and breaks down more of it (higher MMP activity). Any treatment that claims to “repair” aged skin needs to act on these processes.
MSCs act mainly by releasing signals, not by turning into new skin cells. They secrete growth factors, such as TGF-beta, VEGF and fibroblast growth factor, and tiny vesicles called exosomes. In laboratory and animal studies, these signals have been shown to:
A review of MSCs in skin rejuvenation summarises these effects as increased collagen and elastic fibres, inhibition of MMP activation, and protection from UV-induced senescence (Jo et al., 2021).
UC-MSCs come from the Wharton’s jelly of umbilical cords donated after healthy births. Compared with MSCs taken from an adult’s own fat or bone marrow, they:
One study found that the growth-factor-rich fluid from cultured UC-MSCs (called conditioned medium) contained higher levels of active factors than the same fluid from fat-derived MSCs, and worked better in aged mice (Ahn et al., 2025). That is an animal finding, not proof of a better result in people.
| 📌 If you’re interested in why umbilical cord cells are often preferred over bone marrow or fat-derived cells, we have an interesting article that discusses why UC-MSCs are superior to other stem cell sources, which you can read via the internal link. |
This is the most important question, and the answer is: very little so far, especially for injected living cells. To make this clear, the table separates laboratory, animal and human evidence.
| Study | Type | What was tested | Main finding |
| Ahn et al., 2025, Efficacy and safety of umbilical cord-derived MSC-conditioned media for preventing and treating skin aging | Lab + animal | UC-MSC conditioned medium (cell-free) on skin cells and aged mice | More fibroblast growth; thicker skin and more collagen in aged mice; passed animal safety tests (source) |
| Xiong et al., 2024, Preventive effect of human umbilical cord MSCs on skin aging in rats | Animal | Living UC-MSCs in rats given an aging-inducing chemical | Thicker skin, more dermal vessels, more type I and III collagen, less MMP-1 (source) |
| Xia et al., 2025, Repeat-dose toxicity of human umbilical cord MSCs via subcutaneous injection in NOG mice | Animal safety | Repeated injections of living UC-MSCs under the skin | No major toxicity at the lower dose; lumps at the injection site at the high dose (source) |
| Liang et al., 2022 | Human, randomized split-face, 28 people | UC-MSC conditioned medium (cell-free) with microneedling vs microneedling with saline | Better brightness, texture and elasticity on the treated side; no serious side effects; 2 weeks of follow-up (source) |
| Role of Mesenchymal Stem Cells in Skin Aging and Damage, 2025 | Review | Summary of MSCs and MSC-based products for skin aging | Promising candidates, but more clinical research is needed (source) |
Safety must be taken as seriously as benefit, especially for a cosmetic treatment given to healthy people.
Reported or expected short-term side effects include:
The biggest real-world risk is product quality. Regulators abroad have warned about stem cell products contaminated with bacteria, which have caused serious infections (Spectrum, 2019).
There is no evidence that properly made UC-MSCs form tumours in people. But the question cannot yet be fully answered, for three reasons:
For these reasons, any suspicious spot should be checked by a dermatologist before treatment, and cells should only be used if they pass genetic stability testing (see below).
Stem cell treatment for skin aging is not suitable for people who:
Cell quality is where safe and unsafe providers differ most. A clinic that runs its own laboratory should be able to show you a Certificate of Analysis (COA) for every batch, covering these tests:
| Test | What it checks | Why it matters |
| Donor screening | Mother’s medical history and blood tests (HIV, hepatitis B and C, syphilis and others) | Prevents passing on infections |
| Identity (surface markers) | Cells carry MSC markers (CD73, CD90, CD105) and lack blood cell markers | Confirms they really are MSCs |
| Cell count and viability | How many cells there are, and what percentage are alive | Confirms the dose |
| Sterility | No bacteria or fungi | Prevents infection |
| Mycoplasma | No mycoplasma, a tiny bacterium that standard tests miss | Hidden contamination |
| Endotoxin | Low bacterial toxin levels | Prevents fever and inflammatory reactions |
| Genetic stability (karyotype) | Normal chromosomes after growth in the lab | Reduces the risk of abnormal cells |
| Passage number | How many times the cells have been grown and split | Older cultures are more likely to change |
This is important to know before you book. Under the Medical Council of Thailand’s rules, routine stem cell treatment is permitted only for a short list of blood disorders. Thai officials have stated that stem cell injections outside those permitted uses, when openly advertised by clinics, are illegal (The Nation, 2024). The Medical Council has also said it will not approve stem cell research for cosmetic purposes.
| 📌 If you’re planning treatment in Thailand and want a practical checklist for choosing a safe clinic, we have an interesting article that discusses whether stem cell therapy is safe in Thailand, which you can read via the internal link. |
The rules are changing. A recent Ministry of Public Health decree classifies expanded cells such as MSCs as Advanced Therapy Medicinal Products, which must be made in GMP facilities and registered with the Thai FDA. A government programme to develop these products lists dermatological and anti-aging conditions among its targets.
Mesenchymal stem cells target real biology in aging skin. In the lab and in animals, they boost collagen, lower collagen-breaking enzymes and reduce cell stress. In people, the evidence is still early, small and mostly limited to cell-free products. Safety in healthy people over the long term is not yet known, and in Thailand the legal status of cosmetic stem cell injections is restrictive.
The best-proven ways to protect aging skin remain daily sunscreen, not smoking, retinoids prescribed or recommended by a dermatologist, and established procedures. For details on specific concerns, see our pages on wrinkles, sagging skin, collagen production, facial rejuvenation, acne scars and treatment costs.
Mesenchymal stem cells (MSCs) are cells that can release growth factors and other signals that support tissue repair. For skin aging, researchers are studying whether these signals can help fibroblasts make more collagen, reduce collagen breakdown and calm inflammation in the dermis. MSCs can come from fat, bone marrow or umbilical cord tissue. Their use for skin aging is still experimental.
Possibly, but this has only been shown in the lab and in animals. One study found that the conditioned medium from umbilical cord MSCs contained more active factors than the medium from fat-derived MSCs, and it worked better in aged mice. No study has compared the two directly in people. Umbilical cord cells also avoid a fat harvesting procedure.
Mostly, no. MSCs are thought to work mainly by releasing signals, such as growth factors and exosomes, that act on the skin’s own cells. Their main target is the fibroblast, the cell that makes collagen. The skin’s own cells do the rebuilding.
| 📌 If you’re interested in how MSCs shift the immune system from attack mode to repair mode, we have an interesting article that discusses mesenchymal stem cell therapy for immune modulation, which you can read via the internal link. |
They are very different products:
This is not known. The largest human study of a UC-MSC product (a cell-free conditioned medium) measured results only 2 weeks after the last treatment. No study has followed people for long enough to show how long any benefit lasts. Be cautious of any provider that promises results lasting years.
No treatment reverses skin aging. In animal studies, MSCs increased skin thickness and collagen and reduced MMP-1, an enzyme that breaks down collagen (Xiong et al., 2024). Whether this leads to a lasting, visible improvement in people has not been shown.
No. The U.S. FDA has not approved any stem cell product for skin aging or cosmetic use. In Thailand, a new decree classifies expanded cells such as MSCs as medicines that must be registered with the Thai FDA. Ask any provider which registration or approval covers the product it uses.
Injecting stem cells for cosmetic purposes is not a permitted routine treatment in Thailand. Thai officials have stated that stem cell injections outside the uses specified by the Medical Council, when openly advertised by clinics, are illegal. The regulations are being updated, so ask the clinic for written proof of the approval that covers its treatment.
There is no evidence that properly made UC-MSCs form tumours in people. However, long-term safety data in healthy cosmetic users are missing. MSC signals encourage cell growth and new blood vessels, which in theory could help an undetected skin cancer grow. Have any suspicious spot checked by a dermatologist first, and only accept cells that have passed genetic stability testing.
The most common are redness, swelling, bruising and tenderness at the injection sites, usually for a few days. Lumps under the skin can occur. In a mouse safety study, lumps appeared at the injection site at the higher dose. The most serious risk is infection from a contaminated product, which is why batch testing matters.
People who have or have had cancer, especially skin cancer; who are pregnant or breastfeeding; who have an active skin infection; who take strong immune-suppressing drugs; who have a bleeding disorder or a history of keloid scars; or who expect dramatic, permanent results. See the full list in the safety section above.
Daily broad-spectrum sunscreen, avoiding smoking, and topical retinoids are the best-proven measures. UV light causes most visible facial aging, so sun protection does more for most people than any regenerative treatment. A dermatologist can advise on established procedures for specific concerns.